• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Anergic CD8+ T lymphocytes have impaired NF-κB activation with defects in p65 phosphorylation and acetylation.无反应性 CD8+ T 淋巴细胞的 NF-κB 激活受损,p65 磷酸化和乙酰化缺陷。
J Immunol. 2012 Feb 1;188(3):1213-21. doi: 10.4049/jimmunol.1100793. Epub 2011 Dec 28.
2
Critical role of B cell lymphoma 10 in BAFF-regulated NF-κB activation and survival of anergic B cells.B 细胞淋巴瘤 10 在 BAFF 调节的 NF-κB 激活和失能 B 细胞存活中的关键作用。
J Immunol. 2012 Dec 1;189(11):5185-93. doi: 10.4049/jimmunol.1102952. Epub 2012 Oct 19.
3
Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65.人1型嗜T细胞病毒tax诱导具有生物活性的核因子-κB需要IkappaB激酶-1介导的RelA/p65磷酸化。
J Biol Chem. 2004 Apr 30;279(18):18137-45. doi: 10.1074/jbc.M401397200. Epub 2004 Feb 12.
4
NF-kappaB-dependent transcriptional activation in lung carcinoma cells by farnesol involves p65/RelA(Ser276) phosphorylation via the MEK-MSK1 signaling pathway.法尼醇在肺癌细胞中通过MEK-MSK1信号通路使p65/RelA(Ser276)磷酸化从而介导核因子κB依赖的转录激活。
J Biol Chem. 2008 Jun 13;283(24):16391-9. doi: 10.1074/jbc.M800945200. Epub 2008 Apr 18.
5
Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitors.IKK 介导的 RelA 丝氨酸 536 磷酸化的破坏使人类多发性骨髓瘤细胞对组蛋白去乙酰化酶(HDAC)抑制剂敏感。
J Biol Chem. 2011 Sep 30;286(39):34036-50. doi: 10.1074/jbc.M111.284216. Epub 2011 Aug 4.
6
Hyper--GlcNAcylation activates nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) signaling through interplay with phosphorylation and acetylation.O-连接的N-乙酰葡糖胺化通过与磷酸化和乙酰化的相互作用激活活化B细胞的核因子κ轻链增强子(NF-κB)信号通路。
J Biol Chem. 2017 Jun 2;292(22):9150-9163. doi: 10.1074/jbc.M116.766568. Epub 2017 Apr 17.
7
A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.一种涉及IKKβ和p65/RelA丝氨酸536磷酸化的新型核因子-κB(NF-κB)信号通路在缺乏NF-κB转录活性的情况下导致p53抑制。
J Biol Chem. 2005 Mar 18;280(11):10326-32. doi: 10.1074/jbc.M412643200. Epub 2004 Dec 20.
8
Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.蛋白激酶Cθ、Bcl10或Malt1的缺失选择性地损害CD4 + T细胞亚群中的增殖和NF-κB激活。
J Immunol. 2008 Nov 1;181(9):6244-54. doi: 10.4049/jimmunol.181.9.6244.
9
Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.Akt通过利用IκB激酶并激活丝裂原活化蛋白激酶p38来刺激NF-κB的RelA/p65亚基的反式激活潜能。
J Biol Chem. 2001 Jun 1;276(22):18934-40. doi: 10.1074/jbc.M101103200. Epub 2001 Mar 20.
10
IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300.IκB激酶α介导的SMRT去抑制增强了p300对RelA/p65的乙酰化作用。
Mol Cell Biol. 2006 Jan;26(2):457-71. doi: 10.1128/MCB.26.2.457-471.2006.

引用本文的文献

1
A mechanistic quantitative systems pharmacology model platform for translational efficacy evaluation and checkpoint combination design of bispecific immuno-modulatory antibodies.用于双特异性免疫调节抗体的转化疗效评估和检查点联合设计的机制性定量系统药理学模型平台。
Front Pharmacol. 2025 Apr 10;16:1571844. doi: 10.3389/fphar.2025.1571844. eCollection 2025.
2
The diversity of CD8 T cell dysfunction in cancer and viral infection.癌症和病毒感染中CD8 T细胞功能障碍的多样性。
Nat Rev Immunol. 2025 Apr 11. doi: 10.1038/s41577-025-01161-6.
3
Peroxisome Proliferator-Activated Receptor δ Suppresses the Cytotoxicity of CD8+ T Cells by Inhibiting RelA DNA-Binding Activity.过氧化物酶体增殖物激活受体 δ 通过抑制 RelA 的 DNA 结合活性来抑制 CD8+ T 细胞的细胞毒性。
Cancer Res Commun. 2024 Oct 1;4(10):2673-2684. doi: 10.1158/2767-9764.CRC-24-0264.
4
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer.NF-κB 亚基 RelA 和 c-Rel 选择性地控制多发性硬化症和癌症中的 CD4+ T 细胞功能。
J Exp Med. 2024 Jun 3;221(6). doi: 10.1084/jem.20231348. Epub 2024 Apr 2.
5
Key oncogenic signaling pathways affecting tumor-infiltrating lymphocytes infiltration in hepatocellular carcinoma: basic principles and recent advances.影响肝癌肿瘤浸润淋巴细胞浸润的关键致癌信号通路:基本原则和最新进展。
Front Immunol. 2024 Feb 15;15:1354313. doi: 10.3389/fimmu.2024.1354313. eCollection 2024.
6
HMOX1 pathway signature predicts clinical benefit from immunotherapy plus tyrosine kinase inhibitor therapy in advanced renal cell carcinoma.HMOX1 通路特征可预测晚期肾细胞癌免疫治疗联合酪氨酸激酶抑制剂治疗的临床获益。
Cancer Med. 2023 May;12(9):10512-10525. doi: 10.1002/cam4.5787. Epub 2023 Apr 9.
7
RELA tunes innate-like interferon I/III responses in human T cells.RELA 调节人类 T 细胞中的固有样干扰素 I/III 反应。
J Exp Med. 2023 May 1;220(5). doi: 10.1084/jem.20220666. Epub 2023 Feb 23.
8
Calf Thymus Polypeptide Restrains the Growth of Colorectal Tumor Regulating the Intestinal Microbiota-Mediated Immune Function.小牛胸腺多肽通过调节肠道微生物群介导的免疫功能抑制结直肠癌的生长。
Front Pharmacol. 2022 May 19;13:898906. doi: 10.3389/fphar.2022.898906. eCollection 2022.
9
HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer.组蛋白去乙酰化酶 5 通过去乙酰化 p65 调节胰腺癌细胞程序性死亡配体 1 表达和肿瘤免疫
Theranostics. 2022 Jan 31;12(5):2080-2094. doi: 10.7150/thno.69444. eCollection 2022.
10
Ubiquitin Activating Enzyme UBA6 Regulates Th1 and Tc1 Cell Differentiation.泛素激活酶 UBA6 调节 Th1 和 Tc1 细胞分化。
Cells. 2021 Dec 29;11(1):105. doi: 10.3390/cells11010105.

本文引用的文献

1
Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling.SETD6 通过组蛋白甲基转移酶 GLP 将 NF-κB 亚基 RelA 的赖氨酸甲基化,将组蛋白甲基转移酶 GLP 的活性与 NF-κB 信号的持续抑制偶联。
Nat Immunol. 2011 Jan;12(1):29-36. doi: 10.1038/ni.1968. Epub 2010 Dec 5.
2
Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation.谷氨酰胺摄取和代谢在 T 淋巴细胞激活过程中通过 ERK/MAPK 协调调节。
J Immunol. 2010 Jul 15;185(2):1037-44. doi: 10.4049/jimmunol.0903586. Epub 2010 Jun 16.
3
Specification of DNA binding activity of NF-kappaB proteins.NF-κB 蛋白的 DNA 结合活性的说明。
Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000067. doi: 10.1101/cshperspect.a000067.
4
Mechanisms maintaining peripheral tolerance.维持外周耐受的机制。
Nat Immunol. 2010 Jan;11(1):21-7. doi: 10.1038/ni.1817. Epub 2009 Dec 17.
5
Peripheral tolerance in CD8+ T cells.CD8+ T细胞的外周耐受
Cytokine. 2009 May;46(2):147-59. doi: 10.1016/j.cyto.2009.01.010. Epub 2009 Mar 5.
6
The kinase PDK1 integrates T cell antigen receptor and CD28 coreceptor signaling to induce NF-kappaB and activate T cells.激酶PDK1整合T细胞抗原受体和CD28共受体信号,以诱导核因子-κB并激活T细胞。
Nat Immunol. 2009 Feb;10(2):158-66. doi: 10.1038/ni.1687. Epub 2009 Jan 4.
7
New regulators of NF-kappaB in inflammation.炎症中NF-κB的新型调节因子
Nat Rev Immunol. 2008 Nov;8(11):837-48. doi: 10.1038/nri2423.
8
Reciprocal NFAT1 and NFAT2 nuclear localization in CD8+ anergic T cells is regulated by suboptimal calcium signaling.CD8⁺无反应性T细胞中相互作用的NFAT1和NFAT2核定位受次优钙信号调节。
J Immunol. 2007 Sep 15;179(6):3734-41. doi: 10.4049/jimmunol.179.6.3734.
9
PKCtheta cooperates with atypical PKCzeta and PKCiota in NF-kappaB transactivation of T lymphocytes.蛋白激酶Cθ(PKCθ)与非典型蛋白激酶Cζ(PKCζ)和蛋白激酶Ciota(PKCiota)协同作用,促进T淋巴细胞的核因子κB(NF-κB)转录激活。
Mol Immunol. 2008 Jan;45(1):117-26. doi: 10.1016/j.molimm.2007.05.003. Epub 2007 Jun 22.
10
Differential regulation of p65 and c-Rel NF-kappaB transactivating activity by Cot, protein kinase C zeta and NIK protein kinases in CD3/CD28 activated T cells.在CD3/CD28激活的T细胞中,Cot、蛋白激酶C ζ和NIK蛋白激酶对p65和c-Rel核因子-κB转录激活活性的差异调节
Cell Signal. 2007 Mar;19(3):528-37. doi: 10.1016/j.cellsig.2006.08.002. Epub 2006 Aug 23.

无反应性 CD8+ T 淋巴细胞的 NF-κB 激活受损,p65 磷酸化和乙酰化缺陷。

Anergic CD8+ T lymphocytes have impaired NF-κB activation with defects in p65 phosphorylation and acetylation.

机构信息

Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD 20742, USA.

出版信息

J Immunol. 2012 Feb 1;188(3):1213-21. doi: 10.4049/jimmunol.1100793. Epub 2011 Dec 28.

DOI:10.4049/jimmunol.1100793
PMID:22205033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3262885/
Abstract

Because of the cytotoxic potential of CD8(+) T cells, maintenance of CD8(+) peripheral tolerance is extremely important. A major peripheral tolerance mechanism is the induction of anergy, a refractory state in which proliferation and IL-2 production are inhibited. We used a TCR transgenic mouse model to investigate the signaling defects in CD8(+) T cells rendered anergic in vivo. In addition to a previously reported alteration in calcium/NFAT signaling, we also found a defect in NF-κB-mediated gene transcription. This was not due to blockade of early NF-κB activation events, including IκB degradation and NF-κB nuclear translocation, as these occurred normally in tolerant T cells. However, we discovered that anergic cells failed to phosphorylate the NF-κB p65 subunit at Ser(311) and also failed to acetylate p65 at Lys(310). Both of these modifications have been implicated as critical for NF-κB transactivation capacity, and thus, our results suggest that defects in key phosphorylation and acetylation events are important for the inhibition of NF-κB activity (and subsequent T cell function) in anergic CD8(+) T cells.

摘要

由于 CD8(+) T 细胞的细胞毒性潜力,维持 CD8(+)外周耐受极其重要。主要的外周耐受机制是诱导无反应性,即增殖和 IL-2 产生受到抑制的一种不应答状态。我们使用 TCR 转基因小鼠模型研究了体内诱导无反应性的 CD8(+) T 细胞的信号缺陷。除了先前报道的钙/NFAT 信号改变外,我们还发现 NF-κB 介导的基因转录存在缺陷。这并不是由于早期 NF-κB 激活事件的阻断,包括 IκB 降解和 NF-κB 核易位,因为这些事件在耐受 T 细胞中正常发生。然而,我们发现无反应性细胞不能使 NF-κB p65 亚基在 Ser(311)磷酸化,也不能使 p65 在 Lys(310)乙酰化。这两种修饰都被认为对 NF-κB 反式激活能力至关重要,因此,我们的结果表明,关键磷酸化和乙酰化事件的缺陷对于抑制无反应性 CD8(+) T 细胞中的 NF-κB 活性(以及随后的 T 细胞功能)非常重要。